Cancer is a complex, heterogeneous disease that often transforms into therapy-resistant forms. Pharmacological agents have long been used for cancer treatment, but new approaches are required to make tumors penetrable and treatable. In this webinar, scientists will discuss how they identify and design new cell-based anticancer treatments and how they balance the need for potency with the specter of side effects.
Topics to be covered
Khalid Shah, PhD
Vice-Chair of Research, Brigham and Women's Hospital
Director, Center for Stem Cell Therapeutics and Imaging
Associate Professor, Harvard Medical School
Faculty, Harvard Stem Cell Institute